Antibiotic adjuvants: diverse strategies for controlling drug-resistant pathogens.
about
New Perspectives on the Use of Phytochemicals as an Emergent Strategy to Control Bacterial Infections Including BiofilmsAntimicrobial Activity of Lactoferrin-Related Peptides and Applications in Human and Veterinary MedicineEvaluation of the Interaction between the Poincianella pyramidalis (Tul.) LP Queiroz Extract and Antimicrobials Using Biological and Analytical ModelsChemogenomics and orthology-based design of antibiotic combination therapiesEfficacy of ampicillin against methicillin-resistant Staphylococcus aureus restored through synergy with branched poly(ethylenimine)Endless Resistance. Endless Antibiotics?Structural and functional plasticity of antibiotic resistance nucleotidylyltransferases revealed by molecular characterization of lincosamide nucleotidylyltransferases lnu(A) and lnu(D).The licorice pentacyclic triterpenoid component 18β-glycyrrhetinic acid enhances the activity of antibiotics against strains of methicillin-resistant Staphylococcus aureus.Rethinking the Antibiotic Discovery ParadigmBranched Peptide, B2088, Disrupts the Supramolecular Organization of Lipopolysaccharides and Sensitizes the Gram-negative Bacteria.High therapeutic efficacy of Cathelicidin-WA against postweaning diarrhea via inhibiting inflammation and enhancing epithelial barrier in the intestineBerberine Is a Novel Type Efflux Inhibitor Which Attenuates the MexXY-Mediated Aminoglycoside Resistance in Pseudomonas aeruginosaQuorum sensing signal-response systems in Gram-negative bacteria.Biogenic selenium nanoparticles: characterization, antimicrobial activity and effects on human dendritic cells and fibroblasts.Small steps to new drugs for bugs.Identifying components required for OMP biogenesis as novel targets for antiinfective drugs.Pseudomonas aeruginosa: targeting cell-wall metabolism for new antibacterial discovery and development.Potential role of probiotics in the management of gastric ulcer.Designing metallodrugs with nuclease and protease activity.New Roads Leading to Old Destinations: Efflux Pumps as Targets to Reverse Multidrug Resistance in Bacteria.Conessine as a novel inhibitor of multidrug efflux pump systems in Pseudomonas aeruginosa.Membrane-active macromolecules kill antibiotic-tolerant bacteria and potentiate antibiotics towards Gram-negative bacteria.Probiotic supplementation protects weaned pigs against enterotoxigenic Escherichia coli K88 challenge and improves performance similar to antibiotics.Bifunctional antimicrobial conjugates and hybrid antimicrobials.Pentamidine sensitizes Gram-negative pathogens to antibiotics and overcomes acquired colistin resistance.Cathelicidin-WA Improves Intestinal Epithelial Barrier Function and Enhances Host Defense against Enterohemorrhagic Escherichia coli O157:H7 Infection.5-Alkyloxytryptamines are membrane-targeting, broad-spectrum antibiotics.Targeting the Type II Secretion System: Development, Optimization, and Validation of a High-Throughput Screen for the Identification of Small Molecule Inhibitors.Structure and Interactions of A Host Defense Antimicrobial Peptide Thanatin in Lipopolysaccharide Micelles Reveal Mechanism of Bacterial Cell Agglutination.The Broad-Spectrum Antimicrobial Potential of [Mn(CO)4(S2CNMe(CH2CO2H))], a Water-Soluble CO-Releasing Molecule (CORM-401): Intracellular Accumulation, Transcriptomic and Statistical Analyses, and Membrane Polarization.Tuning the Effects of Bacterial Membrane Permeability through Photo-Isomerization of Antimicrobial Cationic Amphiphiles.A Drug Repositioning Approach Reveals that Streptococcus mutans Is Susceptible to a Diverse Range of Established Antimicrobials and Nonantibiotics.Antibacterial Activity of 1-[(2,4-Dichlorophenethyl)amino]-3-Phenoxypropan-2-ol against Antibiotic-Resistant Strains of Diverse Bacterial Pathogens, Biofilms and in Pre-clinical Infection Models.Short proline-rich lipopeptide potentiates minocycline and rifampicin against multidrug- and extensively drug-resistant Pseudomonas aeruginosa.Cationic phthalocyanine dendrimers as potential antimicrobial photosensitisers.TonB-Dependent Receptor Repertoire of Pseudomonas aeruginosa for Uptake of Siderophore-Drug Conjugates.Antibiotic Hybrids: the Next Generation of Agents and Adjuvants against Gram-Negative Pathogens?Narrow-Spectrum Antibacterial Agents.Dendrimer mediated clustering of bacteria: improved aggregation and evaluation of bacterial response and viability.Screening for inhibitors of mutacin synthesis in Streptococcus mutans using fluorescent reporter strains.
P2860
Q26741342-1A2DA7EC-5B42-452C-9D8F-3CFB22D5AD58Q26746324-969C984D-A9A2-4D18-94DD-C83A7E57B16DQ28552193-BB8E2A90-7496-40D3-BE2A-0A2B2EE90920Q28817589-794C5496-C554-43D4-82E1-73ED10EDEAF7Q28821040-CBAA2A5E-1254-4804-8CE5-AF8EED35BFACQ28822179-66DF5D91-AEAF-4FD7-B8AB-11D77525E30EQ35613263-889D65FB-A74E-4D03-99E9-0C1BBFEC6387Q35896916-99663A5F-1921-4E64-B473-EEA6070A6570Q35947579-FFC92318-290F-4939-B7E1-82EE269152D9Q36897919-207A0E76-69F3-4973-A359-80A36C1A105BQ36903462-41332CC6-87EA-4AAD-917A-B8A99C36C150Q37154814-FC99CAB0-E2B6-4B83-8479-9110F6B660C4Q37324474-932B1D1F-1FEC-483C-A6BA-ECDFEE2D087AQ37353486-28E3BBA8-E639-4B2E-AFCE-D6F50EE44744Q38292997-31088E16-C249-40B0-AC45-C9C2C09099D1Q38766394-E6D5B95C-3F65-4D71-80D8-EBAAD8B820BDQ38844899-ADCDDE80-3637-4229-A3AD-92AED60317B9Q38848225-313B2740-C060-46CF-937B-0B399A0F77A1Q38974558-AECDC51C-B217-40C1-8FA2-DBA4048F7560Q39179301-59919A9D-F733-4482-BB99-1B85DE2DEBC0Q40043441-8D0F9521-F9A4-4BE0-8996-AA2A32D1CA41Q40072170-CB2B297A-8A1C-4D7E-ACF4-DCC775A0928EQ40126694-334E63E2-1361-440E-8BBA-2AB5AB8152E4Q40203926-0EDB6410-0D0B-4F8E-8AFC-505BF474AD2EQ40306876-D48DC6B5-508F-40FF-85D7-240861BB2A0CQ40381763-83CFCC9E-E642-4BF6-8BB2-56F03BC5F2D5Q40495313-F80AAC14-A7E9-4AFD-9281-4E48425BFD5CQ46308613-1D4FBB37-CE2F-46C3-B040-B1FEE3BF7FC9Q47142029-A0C50E8B-D982-40DA-9401-CA9948087F4EQ47722784-454B1FB7-CE8D-4048-9D21-9A53AFD7D477Q48095319-35A8D307-FFF5-4D71-BDA0-F6C04331112AQ48143477-30C2B8AD-E6C5-46DB-8FEC-E451897C5124Q49182957-8500BDCC-D454-4946-AF53-C40FD6519A8FQ50044323-E1E5B169-DACA-4B45-B4D3-D662508D041AQ50087494-91D4AAF6-E722-4642-A6EA-51C18CEA11C1Q52349917-7F7682A9-3DAD-44D5-8D0D-375FD68AB69AQ52655525-16FCF33C-BD4C-4605-93A9-943168C9394FQ53703028-139C9704-53F9-4FDF-9E9A-8BE3791C93B4Q54503500-C5DB5C83-AE33-4347-8548-883F8EA6AC81Q55042084-CC8FCB34-1716-4A68-8078-7BFF291C78B1
P2860
Antibiotic adjuvants: diverse strategies for controlling drug-resistant pathogens.
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Antibiotic adjuvants: diverse strategies for controlling drug-resistant pathogens.
@ast
Antibiotic adjuvants: diverse strategies for controlling drug-resistant pathogens.
@en
Antibiotic adjuvants: diverse strategies for controlling drug-resistant pathogens.
@nl
type
label
Antibiotic adjuvants: diverse strategies for controlling drug-resistant pathogens.
@ast
Antibiotic adjuvants: diverse strategies for controlling drug-resistant pathogens.
@en
Antibiotic adjuvants: diverse strategies for controlling drug-resistant pathogens.
@nl
prefLabel
Antibiotic adjuvants: diverse strategies for controlling drug-resistant pathogens.
@ast
Antibiotic adjuvants: diverse strategies for controlling drug-resistant pathogens.
@en
Antibiotic adjuvants: diverse strategies for controlling drug-resistant pathogens.
@nl
P2860
P356
P1476
Antibiotic adjuvants: diverse strategies for controlling drug-resistant pathogens
@en
P2093
Erin E Gill
P2860
P356
10.1111/CBDD.12478
P577
2015-01-01T00:00:00Z